Search by Practice
Insights & News / Ido Freund
Barnea: Representing Daily.dev in USD 11 Million Seed Funding Round
Itay Gura, Ido Freund, and Inbar Katzir represented the Israeli startup Daily.dev in a USD 11 million seed funding round. The company aims to build the world’s largest professional network for the global developer community.
Barnea: Supporting ReCombinate Program
We are happy to be a partner in the ReCombinant program, an AB InBev-TAU Ventures collaboration dedicated to fostering pilot activity and joint R&D. The program is supported by the Israel Innovation Authority. Ido Freund, a partner in our Corporate Department, served as a speaker on a panel at the initiative’s spotlight event.
Barnea: Representing Israeli Startup in Initial Funding Round of USD 17 million
Itay Gura, Ido Freund, and Inbar Katzir represented the startup Winn.AI in an initial funding round of USD 17 million. Winn.AI offers a real-time AI assistant that helps sales teams win more deals with less hassle through its innovative real-time tracking, capturing, and CRM updating features.
BioGenCell Completes USD 16 Million Seed Round
Our firm represents BioGenCell, a stem cell research and development company located at Laniado Hospital. The company recently announced the completion of a USD 16 million seed round investment, aided by counsel from Advs. Itay Gura, Ido Freund, and Inbar Katzir. Our firm has represented the company since its inception.
Representing BlueVine in Investment Round in Bizi
Itay Gura, Ido Freund, and Inbar Katzir represented BlueVine, a fintech company operating in the US that provides a banking platform for small and medium-sized businesses, in its first investment in an Israeli company. BlueVine led the USD 7.5 million investment in Bizi and will also grant Bizi a license for its platform to provide services in Israel.
Legal Tools Workshop for Entrepreneurs in EdTech Program
Our firm represents EdTech Israel, a project to promote technological innovation in the fields of education and learning. In a meeting held today, Itay Gura, Yuval Lazi, and Ido Freund lectured to the venture's participants on founders’ agreements, intellectual property, and financing agreements, respectively.
jumpTAU Accelerator and Barnea Embark on New Cycle
A new cycle of the jumpTAU accelerator program, from Tel Aviv University, has begun. The accelerator supports multicultural ventures, in an effort to promote cooperation between Arab and Jewish entrepreneurs.
Our firm advises the accelerator as part of a broad collaboration with Tel Aviv University. In a meeting held today, four of our attorneys lectured to the entrepreneurs on a number of relevant topics.
Daniel Lorber lectured on founders’ agreements, Itay Gura lectured on startup financing, Anat Even-Chen lectured on website regulations and privacy policies, and Ido Freund lectured on intellectual property.
Representing NickNack in Sale to Papaya Global
Yuval Lazi, Itay Gura, Ido Freund, and Inbar Katzir represented the Israeli startup NickNack in its sale to Papaya Global Ltd., a private Israeli company that provides payroll and human resource management computing services to multinational corporations. NickNack is developing a platform that fosters team engagement and togetherness for organizations working remotely.
Representing Danel Group in an Investment in a Medical Technology Company
Our firm’s Micky Barnea, Itay Gura, and Ido Freund represented Danel, a human resources, nursing, and medical services company, in its acquisition of 22% of Aviv Scientific, a leader in improving brain performance and treating the aging process. The transaction’s value is USD 22 million.
Down Round Fundraising – Not At Any Valuation
A recent decision by the Economic Division of the Tel-Aviv District Court has emphasized the requirement for officers and decision makers in a company, to undertake a stricter review standard when making decisions, especially in conflict of interest situations. Accordingly companies must now increase the scrutiny on the decision making of directors in private companies, an important decision in light of the current economic climate.
The Companies Registrar Rears Its Head – Financial Sanctions for Failing to File Reports
The Companies Registrar has recently increased its enforcement efforts when companies failed to submit annual reports, imposing fines amounting to a few thousand shekels on companies that do not comply with the requirements.
Representing Cymplify in Acquisition by Check Point
Our firm represented the IoT security company Cymplify in its acquisition by NASDAQ-listed cloud security company Check Point Software Technologies Ltd. for USD 5 million.
Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan
Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.
Barnea Represents Anzu in Investment Round
Our firm represented the Israeli startup Anzu (Anzu.io) in a USD 6.5 million fundraising round. Anzu developed a platform for game developers that allows the integration of advertisements into the game world. The investment round was led by Advs. Itay Gura and Ido Freund from our Commercial Department.
Barnea Represented Johnson & Johnson Innovation in an Investment Round in Techsomed
Micky Barnea, Ariella Dreyfuss, Itay Gura, Mayer Winkler, and Ido Freund represented Johnson & Johnson Innovation in an investment round in the Israeli medtech startup Techsomed Medical Technologies Ltd. Founded in 2012, Techsomed has developed an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. Techsomed intends to use the funding toward receiving regulatory approval in the US, Europe, and Japan.
JJDC led the company's current round of financing, which included both former and new investors, such as Screen Holdings, the Alfred Mann Institute at the Technion (AMIT), NextLeap Ventures, and Axil Capital.
Barnea Represented JJDC as the Lead Investor in OrthoSpin Ltd.
Our firm represented the US pharmaceutical and medical devices company Johnson & Johnson Development Corporation (JJDC) in a USD 3 million lead investment round in OrthoSpin Ltd. OrthoSpin is an Israeli-based startup that provides smart robotic external fixation systems.
Barnea Represented ADM Capital in Investment in Israeli Startup Rootility
Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.
Barnea & Co. Represented Viola Private Equity in an Investment in Similar Web
Barnea represented Viola Private Equity in an investment of USD 50 million in Similar Web, a leading digital market intelligence platform that provides insights for websites and applications.